Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults.

Munro IA, Garg ML.

Obes Res Clin Pract. 2013 May-Jun;7(3):e173-81. doi: 10.1016/j.orcp.2011.11.001.

PMID:
23697585
2.

Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet.

Munro IA, Garg ML.

Br J Nutr. 2012 Oct 28;108(8):1466-74. doi: 10.1017/S0007114511006817.

PMID:
22214842
3.
4.

Effect of alginate supplementation on weight loss in obese subjects completing a 12-wk energy-restricted diet: a randomized controlled trial.

Georg Jensen M, Kristensen M, Astrup A.

Am J Clin Nutr. 2012 Jul;96(1):5-13. doi: 10.3945/ajcn.111.025312.

5.
6.
7.

Feasibility of ω-3 fatty acid supplementation as an adjunct therapy for people with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.

Fulton AS, Hill AM, Williams MT, Howe PR, Frith PA, Wood LG, Garg ML, Coates AM.

Trials. 2013 Apr 24;14:107. doi: 10.1186/1745-6215-14-107.

8.

Supplementation with n3 fatty acid ethyl esters increases large and small artery elasticity in obese adults on a weight loss diet.

Wong AT, Chan DC, Barrett PH, Adams LA, Watts GF.

J Nutr. 2013 Apr;143(4):437-41. doi: 10.3945/jn.112.169359.

9.

Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults.

Ramel A, Martinéz A, Kiely M, Morais G, Bandarra NM, Thorsdottir I.

Diabetologia. 2008 Jul;51(7):1261-8. doi: 10.1007/s00125-008-1035-7.

PMID:
18491071
10.

Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.

Halpern A, Mancini MC, Suplicy H, Zanella MT, Repetto G, Gross J, Jadzinsky M, Barranco J, Aschner P, Ramirez L, Matos AG.

Diabetes Obes Metab. 2003 May;5(3):180-8.

PMID:
12681025
11.

Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes.

Parker B, Noakes M, Luscombe N, Clifton P.

Diabetes Care. 2002 Mar;25(3):425-30.

PMID:
11874925
12.

Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.

Mohammadi E, Rafraf M, Farzadi L, Asghari-Jafarabadi M, Sabour S.

Asia Pac J Clin Nutr. 2012;21(4):511-8.

13.
14.
15.

Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.

Yee LD, Lester JL, Cole RM, Richardson JR, Hsu JC, Li Y, Lehman A, Belury MA, Clinton SK.

Am J Clin Nutr. 2010 May;91(5):1185-94. doi: 10.3945/ajcn.2009.29036.

17.

A protein-enriched low glycemic index diet with omega-3 polyunsaturated fatty acid supplementation exerts beneficial effects on metabolic control in type 2 diabetes.

Moosheer SM, Waldschütz W, Itariu BK, Brath H, Stulnig TM.

Prim Care Diabetes. 2014 Dec;8(4):308-14. doi: 10.1016/j.pcd.2014.02.004.

PMID:
24656509
18.

Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake.

Lovegrove JA, Brooks CN, Murphy MC, Gould BJ, Williams CM.

Br J Nutr. 1997 Aug;78(2):223-36.

PMID:
9301413
19.
20.

Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals.

Micallef MA, Garg ML.

Atherosclerosis. 2009 Jun;204(2):476-82. doi: 10.1016/j.atherosclerosis.2008.09.020.

PMID:
18977480
Items per page

Supplemental Content

Support Center